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Case Report
Surgical-orthodontic treatment for severe malocclusion in a patient with
osteopetrosis and bilateral cleft lip and palate:
Case report with a 5-year follow-up
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ABSTRACT
Orthognathic surgery in patients with craniofacial osteopetrosis, a condition associated with
osteoclast dysfunction, is usually avoided because of the risk of osteomyelitis. A 19-year-old
woman presented with the chief complaint of severe malocclusion and anterior crossbite. After
radiographic evaluation, craniofacial osteopetrosis was diagnosed. Surgical-orthodontic treatment
was performed after meticulous history taking and verification of normal bone turnover using bone-
metabolism markers for endocrine evaluation. Favorable esthetic and functional outcomes were
achieved. (Angle Orthod. 2021;91:555–563)
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INTRODUCTION
Osteopetrosis is a rare bone disease characterized
by a marked increase in bone density caused by
osteoclast dysfunction.1–3 The German radiologist,
Heinrich Albers-Schönberg, first described the disease
in 1904.4 The prevalence of the disease is 1 in every
100,000 to 500,000 individuals.5 Poorly or non-func-
tioning osteoclasts lead to reductions in bone resorp-
tion and remodeling, resulting in the formation of
sclerotic bone. All the bones in the patient’s body
gradually become denser, with decreased cellularity
and vascularity.6 Nerve compression, owing to the
compromised resorption-remodeling cycle of the bone,
and neurological symptoms such as hearing loss,
visual disturbances, and facial palsy, may occur.
Systemic bone pain, frequent fractures, anemia, and
thrombocytopenia are typical symptoms. The genetic
variability of the disease is responsible for a variety of
phenotypes, which can range from asymptomatic to
fatal. There are three clinical subtypes.6
Autosomal recessive infantile malignant osteopetro-
sis is usually diagnosed during early infancy. It
presents with diffuse skeletal sclerosis, bone marrow
failure, frequent fractures, cranial nerve compression,
and growth impairment. Untreated children usually die
before school age from severe hepatosplenomegaly,
infections, and pancytopenia. Bone marrow transplan-
tation is the only reliable treatment for this condition.7,8
The autosomal recessive intermediate type (marble-
bone disease) is diagnosed in childhood and can
cause neurological complications and dental anoma-
lies.9 Autosomal dominant adult (Albers-Schönberg
disease) osteopetrosis is diagnosed later in life. It is
characterized by less severe symptoms, and the
survival rate is the best among the three types of
osteopetrosis. Symptoms may not be evident in 40% of
patients, and marrow failure is rare.10–12 The typical
features of this type of osteopetrosis are clearly visible
on panoramic tomograms. Cortical bone trabeculation
throughout the jaw bones, except the inferior alveolar
nerve canal, is the principal characteristic feature.
Additionally, tooth agenesis, delayed eruption, enamel
hypoplasia, and tooth malformations are common
diagnostic features of osteopetrosis. Severe malocclu-
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sion and dentofacial deformities occur in addition to the
dental anomalies caused by mandibular prognathism
and unerupted teeth.
Few reports have documented active treatment
modalities for dentofacial deformities and malocclusion
in patients with osteopetrosis, owing to the high
probability of osteomyelitis of the jaw bones, especially
the mandible.13 Anemia and neutropenia may result in
poor healing. However, maxillofacial deformities and
dental problems should be treated since they cause
several psychological and social problems. This case
report describes the successful surgical-orthodontic
treatment of an adult osteopetrosis patient with severe
malocclusion and bilateral cleft lip and palate. The
current case report is of surgical-orthodontic treatment
performed in a patient with osteopetrosis, after
confirming normal bone turnover using markers, that




A 19-year-old woman visited the Department of Oral
and Maxillofacial Surgery with the chief complaint of
severe malocclusion and anterior crossbite (Figures 1
and 2). She also had unrepaired bilateral alveolar clefts,
and the maxillary left central incisor showed ectopic
eruption in the premaxilla. She reported a history of
primary repair for bilateral cleft lip and palate before 1
year of age, and scars of the surgery were evident on
the philtrum. Intraoral examination showed loss of
multiple teeth, severe crowding, transverse maxillary
collapse, and dental caries in multiple remaining teeth.
After a thorough radiographic evaluation for dentofacial
deformity, she was diagnosed with a Class III skeletal
malocclusion with maxillary retrusion and mild mandib-
ular prognathism through a cephalometric analysis
(Figure 3). Panoramic tomogram observations of
abnormal bone pattern, overall thickening of the cortical
bone, and sclerosis of the cancellous portion led to
computed tomography (CT) scanning. Bony sclerosis
was observed in the medullary portion of the majority of
the bones of the skull, including the temporal, frontal,
parietal, occipital, zygomatic, maxillary, and mandibular
bones, and discontinuity of alveolar segments was
observed due to unrepaired bilateral alveolar clefts
(Figure 4). The findings were collated, and the patient
was diagnosed with autosomal dominant adult (benign)
type 1 osteopetrosis.
The patient also reported a history of posterior
fixation for thoracolumbar scoliosis at the age of 13
Figure 1. Pretreatment clinical photographs.
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years. There was no other history of surgery. However,
she wore hearing aids for her impaired hearing.
Impaired hearing, caused by sclerosis of the otic canal,
is a typical feature of patients with osteopetrosis.
Treatment Objectives
The objectives of treatment were: (1) to improve the
skeletal pattern and soft tissue profile, (2) to achieve
normal overjet and overbite after the correction of the
anterior crossbite, (3) to relieve the crowding of teeth,
and (4) to achieve an ideal occlusion.
Treatment Alternatives
The following three treatment options were consid-
ered: (1) presurgical orthodontic treatment, followed by
simultaneous bimaxillary orthognathic surgery and
bilateral alveolar cleft repair, (2) bilateral alveolar cleft
repair with iliac bone graft, followed by maxillary
horizontal expansion and camouflage orthodontic
treatment; (3) camouflage orthodontic treatment with
prosthodontic treatment, excluding any bone surgeries.
The first option included bimaxillary orthognathic
surgery and genioplasty for improvements in the
skeletal and soft tissue profiles. Simultaneous alveolar
cleft repair with three-piece Le Fort-I osteotomy to
reduce the overall duration of treatment would follow.
This option enabled maxillary advancement to improve
maxillary hypoplasia due to bilateral cleft lip and palate,
but potential complications such as postoperative
osteomyelitis related to the osteopetrosis could occur.
The second option included maxillary horizontal
expansion after alveolar cleft repair. However, the
prognosis would be unpredictable owing to the severe
collapse of the maxillary arch. Additionally, though
occlusal correction would be possible, correcting the
skeletal deformity would not, and this option had the
possibility of postoperative osteomyelitis related to
alveolar cleft repair as in the first option.
The third option did not include bone surgery,
thereby minimizing potential complications associated
with osteopetrosis. However, this approach had the
most therapeutic limitations because the treatment
results were not guaranteed.
To achieve ideal skeletal and occlusal relationships,
the first option was selected. However, it was decided
that possibility of complications associated with osteo-
petrosis would be evaluated prior to the initiation of
treatment.
Treatment Progress
A combination of surgical-orthodontic treatment was
selected to treat the patient’s chief complaint. As
patients with osteopetrosis show a higher tendency for
Figure 2. Pretreatment dental casts.
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complications such as osteomyelitis owing to de-
creased bone-turnover rate, the patient was referred
for endocrine evaluation, specifically systemic bone-
turnover examination, before the commencement of
treatment. Bone density evaluation showed a Z-score
of 3.2 in the femoral neck, 2.6 in the tibial neck, and 2.0
in the lumbar spine. These results corresponded to
normal bone density. The level of C-telopeptide, a
bone resorption marker, was 0.556 ng/mL. The levels
of osteocalcin and bone alkaline phosphatase (bone
formation markers) were 35.05 ng/mL and 13.6 lg/mL,
respectively. The examination demonstrated a normal
bone turnover rate (Table 1).
The patient did not report any history of pathologic
fracture of the femur, pelvis, or any other bone, or
failure of healing after tooth extraction, which is
commonly observed in patients with osteopetrosis.
Secondary osteomyelitis is the most common compli-
cation of tooth extraction in patients with osteopetrosis,
which did not occur in this patient. Based on this history
and the normal bone turnover rate of the patient,
presurgical orthodontic treatment was decided to be
initiated.
All teeth with hopeless prognoses were extracted
before presurgical orthodontic treatment, and normal
bone healing patterns were observed. Thereafter,
leveling and alignment of teeth for decompensation
was performed for 24 months without any problems,
and the patient’s dentition responded to normal
orthodontic forces (Figure 5).
The patient underwent bimaxillary orthognathic
surgery and alveolar cleft repair with iliac bone grafting
under general anesthesia after presurgical orthodontic
treatment. A three-piece Le Fort-I osteotomy and
alveolar cleft repair with iliac bone graft were per-
formed for expansion of posterior maxillary width,
impaction (2 mm), and maxillary advancement (3
mm). Mandibular setback surgery with intraoral vertical
Figure 4. Pretreatment computed tomography.
Figure 3. Pretreatment lateral and posteroanterior cephalograms,
tracings, and panoramic tomogram.
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Table 1. Pretreatment Serum Level Results for the Evaluation of Bone Remodeling Function
Serum Level Unit References
Estradiol (E2) 101 pg/mL Multi-reference
Thyroid-stimulating hormone 3.96 lIU/mL 0.35~4.94
Luteinizing hormone 11.45 mIU/mL Multi-reference
Follicle-stimulating hormone 4.4 mIU/mL Multi-reference
Parathyroid hormone 65.3 pg/mL 15~65
Insulin-like growth-factor-1 (Somatomedin-C) 185.3 pg/mL 179.9~777.6
Bone alkaline phosphatase 13.6 lg/mL Multi-reference
b-CrossLaps (C-telopeptide) 0.556 ng/mL Premenopausal:  0.573
Osteocalcin 35.05 ng/mL Premenopausal: 11-43
25-hydroxy-vitamin D 11.92 ng/mL Multi-reference
Calcium 9.1 mg/dL 8.5~10.5
Inorganic phosphate 3.7 mg/dL 2.8~4.5
Figure 5. Intraoral photographs and panoramic tomogram after presurgical orthodontic treatment.
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ramus osteotomy was performed for the mandible, and
advancement (8 mm) and reduction (5 mm) genioplas-
ty was performed to improve the chin profile. While
performing the surgical procedures, difficulty in sawing
was noted due to the lack of bone marrow associated
with the increased bone density in osteopetrosis.
Intermaxillary fixation was performed 2 days after
surgery and was maintained for 10 days. After the
removal of intermaxillary fixation, active physiotherapy
was performed in the outpatient department and
functional recovery was achieved. The bony healing
process was checked periodically and normal bone
recovery was radiographically confirmed by computed
tomography scanning 1 year after surgery (Figure 6).
Skeletal changes and maintenance through the sur-
gery were confirmed on the cephalometric superimpo-
sitions (Figure 7).
Postsurgical orthodontic treatment was performed
for approximately 15 months to complete the treatment
and establish stable occlusion (Figures 8 and 9). After
the removal of the fixed orthodontic appliances, dental
implants were placed and prosthetic rehabilitation were
performed for the replacement of missing teeth. The
total treatment duration was approximately 45 months,
including the prosthetic phase of the treatment.
Treatment Results
After the surgical-orthodontic treatment and pros-
thetic rehabilitation, significant improvements in facial
esthetics and occlusion were evident in clinical
photographs (Figure 10). The alveolar cleft repair was
successful, and considerable maxillary advancement
was accomplished. There was no complication related
to osteopetrosis. The patient was followed for 5 years.
The patient desired to remove the titanium miniplates
and screws used in the previous orthognathic surgery.
Figure 6. 3D computed tomography images taken 1 year after the orthognathic surgery.
Figure 7. Superimposition of the lateral cephalogram tracings. (A) preoperation and postoperation. Black, preoperation; red, postoperation; (B)
postoperation and 1 year after operation. Red, postoperation; black, 1 year after operation.
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Successful bone union was confirmed during the
surgical removal of the titanium miniplates (Figure 11).
DISCUSSION
Treatment of osteopetrosis involves stimulating the
osteoclasts or providing alternative sources of osteo-
clasts.10 Bone marrow transplantation is the primary
mode of treatment for infantile osteopetrosis, and
hormonal therapy such as corticosteroid and parathy-
roid hormones can be used.14 Few reports of treatment
for dentofacial deformities in the craniofacial region or
for malocclusion have been reported, due to the high
prevalence of osteomyelitis. The principal strategy for
the treatment of osteopetrosis includes avoiding and
limiting bone surgery whenever possible.13 Therefore,
the only treatment guideline that has been reported
suggests that supportive therapy should be performed,
without active treatment.15 However, because dentofa-
cial deformities or malocclusions may cause several
social and psychological problems, active treatment
may sometimes be essential for improving a patient’s
quality of life.
This is the first report to describe the protocol of
surgical-orthodontic treatment for severe skeletal mal-
occlusion in a patient with autosomal dominant
osteopetrosis. In addition, this case was particularly
rare, as bilateral cleft lip and palate accompanied the
Figure 8. Lateral and posteroanterior cephalograms, tracings, and
panoramic tomogram after postsurgical orthodontic treatment.
Figure 9. Dental casts after postsurgical orthodontic treatment.
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osteopetrosis. This patient could not receive alveolar
cleft repair due to osteopetrosis, and unrepaired
alveolar clefts place significant limitations on treating
the patient with orthodontic therapy alone. Therefore,
surgical-orthodontic treatment was chosen as the
optimal treatment from the available alternatives.
Several dentists argue that treatments such as
dental implants, tooth extractions, maxillofacial sur-
gery, and orthodontic treatment should be avoided in
patients with osteopetrosis, because of the increased
susceptibility to osteomyelitis, which also occurs in
medication-related osteonecrosis of the jaw (MRONJ)
in patients on bisphosphonate therapy.16 However,
because the pathogenesis of osteomyelitis in patients
with osteopetrosis is believed to be similar to that of
MRONJ caused by antiresorptive drugs (ie, osteoclast
deterioration),17 recent experiences with MRONJ have
led to the recognition of the importance of bone-
turnover rate in the treatment of osteopetrosis patients.
As dental extractions, implant placements, and other
surgical procedures are usually performed after restor-
ing the bone-turnover marker levels for prevention of
MRONJ, bone surgeries such as orthognathic surgery,
orthodontic treatment, and placement of dental im-
plants may be possible if bone-turnover rate is normal
in patients with osteopetrosis.
Fortunately, preoperative examination of bone-re-
modeling markers in this patient revealed normal bone-
remodeling functions, evident by uneventful healing
after previous extractions. These findings were en-
Figure 10. Post-treatment clinical photographs.
Figure 11. Intraoperative photographs showing complete bone healing at the osteotomy sites, 5 years after orthognathic surgery.
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couraging for the initiation of surgical-orthodontic
treatment. If the results of the preoperative examination
of bone-remodeling markers had been abnormal,
surgical-orthodontic treatment was to have been
postponed, pending drug therapy to normalize bone-
turnover rate by using teriparatide, a recombinant
parathyroid hormone.18
Although this case report suggests the possibility of
orthodontic treatment accompanying bone surgery for
craniofacial osteopetrosis patients and the results
supported the chosen treatment protocol, evidence
provided by case reports has limitations and may be
misleading. Clinical case-control studies are required
in the future as few such studies have been
conducted.
CONCLUSIONS
 Orthognathic surgery in patients with craniofacial
osteopetrosis, a condition associated with osteoclast
dysfunction, is generally avoided because of the risk
of osteomyelitis. This case report showed that a
favorable surgical-orthodontic treatment outcome
could be achieved when bone turnover is normal,
even in patients with adult osteopetrosis. This case
report highlights the possibility of active bone surgery
in osteopetrosis patients, after endocrine evaluation.
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